share_log

Merck & Co | 4: Statement of changes in beneficial ownership of securities-Officer Litchfield Caroline

SEC announcement ·  Feb 16 05:10
Summary by Futu AI
On February 14, 2024, Caroline Litchfield, EVP & CFO of Merck & Co., Inc. [MRK], completed a sale of 38,291 shares of common stock at a price of $125.50 per share. The transaction resulted in a total market value of $4,805,520.50. Prior to this sale, Litchfield exercised options to acquire the same number of shares at $58.08 per share. Following these transactions, Litchfield's direct holdings in Merck & Co. amounted to 50,908.194 shares of common stock.
On February 14, 2024, Caroline Litchfield, EVP & CFO of Merck & Co., Inc. [MRK], completed a sale of 38,291 shares of common stock at a price of $125.50 per share. The transaction resulted in a total market value of $4,805,520.50. Prior to this sale, Litchfield exercised options to acquire the same number of shares at $58.08 per share. Following these transactions, Litchfield's direct holdings in Merck & Co. amounted to 50,908.194 shares of common stock.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.